1-4 of 4
Ajay Major
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas

Clinical Trials & Observations
Rahul S. Bhansali, Fredrik Ellin, Thomas Relander, Miao Cao, Wenrui Li, Qi Long, Nivetha Ganesan, Robert Stuver, Steven M. Horwitz, Kitsada Wudhikarn, Steven R. Hwang, N. Nora Bennani, Julio Chavez, Lubomir Sokol, Hayder Saeed, Frank Duan, Pierluigi Porcu, Priyanka Pullarkat, Neha Mehta-Shah, Jasmine M. Zain, Miguel Ruiz, Jonathan E. Brammer, Rishab Prakash, Swaminathan P. Iyer, Adam J. Olszewski, Ajay Major, Peter A. Riedell, Sonali M. Smith, Caroline Goldin, Bradley Haverkos, Bei Hu, Tony Z. Zhuang, Pamela B. Allen, Wael Toama, Murali Janakiram, Taylor R. Brooks, Deepa Jagadeesh, Nisha Hariharan, Aaron M. Goodman, Gabrielle Hartman, Paola Ghione, Fatima Fayyaz, Joanna M. Rhodes, Elise A. Chong, James N. Gerson, Daniel J. Landsburg, Sunita D. Nasta, Stephen J. Schuster, Jakub Svoboda, Mats Jerkeman, Stefan K. Barta
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3507–3518.
https://doi.org/10.1182/bloodadvances.2024012800
Published: 2024
Includes: Supplemental data
Journal Articles

Frontline chemoimmunotherapy with nivolumab and dose-adjusted EPOCH in peripheral T-cell lymphoma: a phase 1 trial

Clinical Trials & Observations
Bradley Haverkos, Jasmine Zain, Manali Kamdar, Alexander Neuwelt, Eduardo Davila, Xander Bradeen, Ajay Major, Steven Bair, Jagar Jasem, Clayton Smith, Diana Abbott, Pierluigi Porcu
Journal: Blood Advances
Blood Adv (2024) 8 (3): 708–711.
https://doi.org/10.1182/bloodadvances.2023011526
Published: 2024
Journal Articles

Phase 1/2 study of carfilzomib, pomalidomide, and dexamethasone with and without daratumumab in relapsed multiple myeloma

Clinical Trials & Observations
Benjamin A. Derman, Jeffrey Zonder, Donna Reece, Craig Cole, Jesus Berdeja, Andrew T. Stefka, Ajay Major, Andrew Kin, Kent Griffith, Jagoda Jasielec, Andrzej J. Jakubowiak
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5703–5712.
https://doi.org/10.1182/bloodadvances.2022008866
Published: 2023
Includes: Supplemental data
Journal Articles

Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions

Ajay Major, Jovian Yu, Navika Shukla, Yan Che, Theodore G. Karrison, Rachel Treitman, Manali K. Kamdar, Bradley M. Haverkos, James Godfrey, Melissa A. Babcook, Timothy J. Voorhees, Sophie Carlson, Daria Gaut, Caspian Oliai, Jason T. Romancik, Allison M. Winter, Brian T. Hill, Radhika Bansal, Jose C. Villasboas Bisneto, Imran A. Nizamuddin, Reem Karmali, Lindsey A. Fitzgerald, Deborah M. Stephens, Priyanka A. Pophali, Asaad Trabolsi, Jonathan H. Schatz, Marie Hu, Veronika Bachanova, Michael J. Slade, Nathan Singh, Nausheen Ahmed, Joseph P. McGuirk, Michael R. Bishop, Peter A. Riedell, Justin Kline
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4528–4538.
https://doi.org/10.1182/bloodadvances.2023010016
Published: 2023
Includes: Supplemental data